Medical Equipment

Long-Read Sequencing Market Size Outlook and Demand Growth Across 2026–2030

March 13, 2026March 16, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Long-Read Sequencing Market Over The 2026–2030 Period?

The long-read sequencing market has experienced substantial expansion in recent years. It is forecast to grow from $1.15 billion in 2025 to $1.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 26.8%. The historical rise in this market can be attributed to several factors, including the limitations of short-read sequencing, the expansion of genomics research, technological advancements in nanopore sequencing, the necessity for accurate genome assembly, and increased financial investment in life sciences.

The long-read sequencing market is projected to experience rapid expansion over the coming years. This market is forecast to reach $3.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 26.5%. This anticipated growth during the forecast period is driven by factors such as the clinical uptake of long-read sequencing, decreasing sequencing expenses, the incorporation of AI-based analytical methods, an increase in oncology diagnostics, and the rise of population genomics initiatives. Key trends anticipated during the same period encompass the growing acceptance of long-read technologies, enhanced detection of structural variants, the development of hybrid sequencing techniques, wider application in rare disease genomics, and increased utilization for complex genome assembly.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28259&type=smp

What Drivers Are Expected To Influence The Long-Read Sequencing Market During The Forecast Period?

The growing occurrence of genetic illnesses is anticipated to fuel the expansion of the long-read sequencing market in the future. Genetic diseases are conditions resulting from alterations or mutations in DNA, which may be inherited or arise spontaneously, impacting an individual’s health, development, or bodily functions. The escalating frequency of genetic diseases stems from heightened awareness and progress in diagnostic tools, facilitating earlier and more precise identification of conditions previously undetected. Long-read sequencing improves the management of genetic disorders by offering exceptionally accurate and thorough genomic data, positioning it as an ideal solution for diagnosing intricate and uncommon conditions. This technology lessens diagnostic ambiguity through its ability to identify structural variations and complex mutations, thereby enhancing personalized treatment and aiding clinical decision-making. As an illustration, in October 2024, data from the Cystic Fibrosis Trust, a national charity in the UK, indicated that 11,148 individuals were living with cystic fibrosis (CF) in the UK in 2022, a number that rose to 11,318 by 2023. Consequently, the rising incidence of genetic diseases is a key factor propelling the expansion of the long-read sequencing market.

How Is The Long-Read Sequencing Market Segmented Across Key Categories?

The long-read sequencing market covered in this report is segmented –

1) By Product And Service: Instruments Or Platforms, Consumables And Reagents, Services And Software

2) By Workflow: Pre-Sequencing, Sequencing, Data Analysis

3) By Technology Platform: Single Molecule Real-Time (SMRT) High-Fidelity (HiFi) Sequencing, Synthetic Long-Read Or Linked-Read, Hybrid And Other Emerging

4) By Application: Human Genomics And Rare-Disease Diagnostics, Oncology And Liquid Biopsy, Metagenomics And Microbiome, Transcriptomics, Agri Genomics And Plant Or Animal Breeding, Other Applications

5) By End User: Academic And Research Institutes, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End-Uses

Subsegments:

1) By Instruments Or Platforms: Single-Molecule Real-Time (SMRT) Sequencers, Nanopore Sequencers

2) By Consumables And Reagents: Library Preparation Kits, Sample Preparation Kits, Sequencing Kits

3) By Services And Software: Sequencing Services, Data Analysis Services, Bioinformatics Software

Which Upcoming Trends Are Expected To Influence The Long-Read Sequencing Market?

Leading companies in the long-read sequencing market are focusing on creating innovative solutions, such as HiFi reads, to improve sequencing accuracy, detect intricate genetic variations, and expedite genomic research. High-fidelity (HiFi) reads are defined as extended DNA sequences generated by particular long-read sequencing technologies, providing both considerable read lengths and very low error rates, which facilitates the accurate identification of complex genetic variants and structural variations. For instance, in November 2024, Pacific Biosciences of California Inc., a US-based biotechnology company, launched its Vega system, which is its first benchtop long-read sequencing platform designed for quicker and more accessible genomic analysis. This device is a compact, affordable benchtop long-read sequencer delivering exceptionally accurate HiFi data with 99.9% read accuracy. It enables rapid, versatile sequencing for applications including RNA, targeted, and small genome sequencing, bringing sophisticated genomics capabilities within reach of more laboratories. Vega streamlines workflows through onboard computing and straightforward operation, empowering researchers to efficiently unlock complex genetic insights.

Who Are The Dominant Players Shaping The Long-Read Sequencing Market Landscape?

Major companies operating in the long-read sequencing market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Revvity Inc., Bio-Rad Laboratories Inc., BGI Genomics Co. Ltd., Novogene Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., New England Biolabs Inc., Roche Sequencing Solutions Inc., The Garvan Institute, Element Biosciences Inc., Eurofins Genomics, CD Genomics, BaseClear B.V, France Génomique, GrandOmics Biosciences Co. Ltd., Future Genomics Technologies B.V., MicrobesNG

Read the full long-read sequencing market report here:

https://www.thebusinessresearchcompany.com/report/long-read-sequencing-global-market-report

Which Region Is Forecast To Lead The Long-Read Sequencing Market In Terms Of Market Size?

North America was the largest region in the long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Long-Read Sequencing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28259&type=smp

Browse Through More Reports Similar to the Global Long-Read Sequencing Market 2026, By The Business Research Company

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Dna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Protein Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795